Janssen Pharmaceuticals Inc.
⚠️ Moderate Risk
FEI: 2211100 • Raritan, NJ • UNITED STATES
FEI Number
2211100
Location
Raritan, NJ
Country
UNITED STATESAddress
1000 U.S. Route 202 South, , Raritan, NJ, United States
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
AGR RX
The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 10/20/2020 | 66QCY10PENTOSAN POLYSULFATE SODIUM (URICOSURIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/1/2019 | 61PAY69CANAGLIFLOZIN (ANTI-DIABETIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/21/2017 | 66VDA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/17/2009 | 55YY99PHARMACEUTIC NECESSITIES AND CONTAINERS, N.E.C. | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 8/21/2009 | 64XDK12TRETINOIN (KERATOLYTIC) | 179AGR RX | Southwest Import District Office (SWI-DO) |
| 12/8/2006 | 55YY99PHARMACEUTIC NECESSITIES AND CONTAINERS, N.E.C. | 118NOT LISTED | Florida District Office (FLA-DO) |
| 5/25/2006 | 64GIA07ESTRADIOL (ESTROGEN) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 3/25/2004 | 63TDJ01GUTTA PERCHA (DENTAL RESTORATION AGENT) | 179AGR RX | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Janssen Pharmaceuticals Inc.'s FDA import refusal history?
Janssen Pharmaceuticals Inc. (FEI: 2211100) has 8 FDA import refusal record(s) in our database, spanning from 3/25/2004 to 10/20/2020.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Janssen Pharmaceuticals Inc.'s FEI number is 2211100.
What types of violations has Janssen Pharmaceuticals Inc. received?
Janssen Pharmaceuticals Inc. has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Janssen Pharmaceuticals Inc. come from?
All FDA import refusal data for Janssen Pharmaceuticals Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.